Navigation Links
Accelrys Brings Industry Leaders Together at Life Sciences Symposium
Date:9/26/2013

SAN DIEGO, Sept. 26, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, hosted the Accelrys Life Sciences Symposium on Wednesday, Sept. 25 in London. The daylong symposium featured networking opportunities and presentations on topics including informatics, predictive sciences and externalization solutions from Accelrys and some of its leading global life sciences customers. Attendees also learned about new offerings from Accelrys including Accelrys Insight and Accelrys Insight for Excel. In addition, an extensive set of advanced predictive sciences solutions from Accelrys was announced during the event.

"This year's Life Sciences Symposium was a great success, providing the opportunity for industry colleagues to exchange ideas on some of the most critical challenges facing the life sciences industry today including collaborative partnerships, leveraging external innovation, addressing cost pressures and accelerating time to market," said Adel Laoui, Accelrys' managing director of life sciences. "At this time of significant transformation in the pharmaceutical and health care industries, we are truly inspired by the ways our customers and colleagues are meeting these challenges by better managing their scientific innovation lifecycles, generating greater value out of their existing software portfolios and making significant investments in future growth."

Accelrys representatives along with executives from Sanofi, BT, GSK, MedImmue, Merz and European Lead Factory/University of Dundee spoke at the symposium, giving the following presentations:

  • SHERPA - A New Sanofi R&D Service to Support Drug Discovery Data Exchange with External Partners – Yves Collenot, IS project leader, Sanofi, France
  • Unlocking Real World Health Data – David Brown, chief technology officer, Life Sciences, BT, United Kingdom
  • Engineering Drug Like Properties of Therapeutic Proteins – Martin Strain, associate scientist, MedImmune, United Kingdom
  • IMI European Lead Factory: Introduction & Opportunities – Andrew Pannifer, computational chemist, IMI European Lead Factory/University of Dundee, United Kingdom
  • QSAR Workbench: Enabling Best Practices in Large Scale Model Building – Stephen Pickett, group leader in computational chemistry and informatics, GSK, United Kingdom
  • Informatics Platform for Drug Repurposing at Merz Pharmaceuticals – Pekka Tiikkainen, scientific expert, Merz, Germany
  • Accelrys Next Generation Cheminformatics: Strategy & Progress – Rob Brown, senior director life sciences product management and marketing & Andrew LeBeau, senior product manager, Accelrys, United States
  • Accelrys & Predictive Sciences in Pharmaceutical Research – Adrian Stevens, senior product marketing manager, Accelrys, United Kingdom

The complete agenda, abstracts and speaker biographies from the event are available online. Other products covered during the Symposium include Accelrys QSAR Workbench, Pipeline Pilot, Discovery Studio, Accelrys HEOS and Contur ELN.

About Accelrys, Inc.

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, California, USA, Accelrys employs more than 200 full-time Ph.D scientists. For more information about Accelrys, visit www.accelrys.com.

 

Video with caption: "Accelrys chief executive officer Max Carnecchia discusses Accelrys Insight and Accelrys Insight for Excel, which complete the roll-out of Accelrys' next-generation cheminformatics suite and provide an interactive, collaborative environment for rapid and effective decision-making in drug discovery." Video available at: http://www.youtube.com/watch?v=rlsOovjXvYs

Image with caption: "Industry leaders at the Accelrys Life Sciences Symposium, held in London Sept. 25, 2013." Image available at: http://photos.prnewswire.com/prnh/20130926/SF87099-a

Image with caption: "Accelrys' extensive set of advanced predictive sciences applications and services enable drug discovery teams to investigate and evaluate hypotheses about the chemical or biological behavior of molecules of therapeutic interest in silico prior to costly experimentation." Image available at: http://photos.prnewswire.com/prnh/20130926/SF87099-b


'/>"/>
SOURCE Accelrys, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Accelrys Transforms Innovation by Bridging Cheminformatics and Bioinformatics
2. Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software for Improved Quality Control and Regulatory Compliance
3. Accelrys Announces Strategic Partnership with USDM
4. Accelrys Materials Studio Release 6.1 Speeds Innovation with Enterprise Capabilities
5. Science Imprisoned: Barcelona Meeting Brings Attention to Cases of Constraint
6. ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making
7. Bend, Twist, Pose – Kitware’s Bender Brings Movement to the Visible Man
8. Breath study brings roadside drug testing closer
9. GLM Displays Brings Flip™ Fabric Displays to its Online Catalogue
10. World Kidney Day Symposium at Allegheny General Hospital Brings Attention to Disease that Afflicts 26 Million People in U.S.
11. DebMed Brings Focus on Patient Safety to HIMSS 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... BEACH, Florida , February 11, 2016 /PRNewswire/ ... PositiveID Corporation ("PositiveID" or "Company") (OTCQB: PSID), ... diagnostics, announced today that its Thermomedics subsidiary, which ... progress on its growth plan in January 2016, ... products distributors, increasing sequential monthly sales growth, and ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... pleased to announce that Mitsui & Co. Ltd., its ... succinic acid plant, is investing an additional CDN$25 million ... increasing its stake from 30% to 40%.  Mitsui will ... bio-succinic acid produced in Sarnia , ...
(Date:2/10/2016)... , ... February 10, 2016 ... ... today announced that it has joined the Human Vaccines Project, a public-private ... diseases and cancer. , The Human Vaccines Project brings together leading ...
(Date:2/10/2016)... Springfield, MO (PRWEB) , ... February 10, 2016 ... ... company, will attend the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter ... of ISPE is expecting to fill more than 100 tables for its annual ...
Breaking Biology Technology:
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... MedNet,s significant achievements are the result of the company,s ... iMedNet eClinical , it,s comprehensive, easy-to-use and ... --> Key MedNet growth achievements in ...
(Date:1/18/2016)... Jan. 18, 2016  Extenua Inc., a pioneering ... the use and access of ubiquitous on-premise and ... with American Cyber.  ... leading transformational C4ISR and Cyber initiatives in support ... latest proven technology solutions," said Steve Visconti ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
Breaking Biology News(10 mins):